WeVote

Bill

Bill

SB 1579

RELATING TO PHARMACISTS.

2026 Regular Session Introduced by Stanley Chang and 4 co-sponsors

Hawaii SB 1579 proposes changes to pharmacist regulations or services; referred to committees and carried over to 2026 for further consideration.

Carried over to 2026 Regular Session.
0
WeVote Research Nonpartisan
Bill Summary · SB 1579

Legislative bill overview

SB 1579 is a Hawaii bill relating to pharmacists that was introduced in January 2025 and referred to the Health and Human Services (HHS) and Consumer Protection (CPN) committees. The bill was carried over to the 2026 regular session without being voted on during the 2025 session, indicating it requires further deliberation or lacks immediate consensus.

Why is this important

Pharmacist-related legislation can significantly impact healthcare delivery, patient access to medications, and the scope of services available in communities. Changes to pharmacist regulations or responsibilities affect both the healthcare workforce and the patients they serve, particularly in Hawaii where geographic isolation may limit healthcare access on certain islands.

Potential points of contention

  • Scope of practice expansion: The bill may propose expanded clinical roles for pharmacists (such as vaccinations, medication therapy management, or prescribing authority), which could face opposition from physicians concerned about professional boundaries or support from patient advocates seeking expanded access.
  • Regulatory and licensing requirements: Changes to pharmacist licensing, education, or continuing education requirements could affect existing practitioners and create compliance costs.
  • Implementation costs: New pharmacist services or expanded roles may require funding, training, or infrastructure changes that could be contentious between legislators concerned about state budget impacts.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.